Actively Recruiting
The Trajectory of Blood Pressure During Pregnancy in Assisted Reproductive Females
Led by The Second Hospital of Shandong University · Updated on 2024-05-23
2000
Participants Needed
1
Research Sites
138 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The incidence of gestational hypertension and preeclampsia in the assisted reproductive technology population during pregnancy was significantly higher than that in the general normal pregnancy population. The use of assisted reproductive technology in this population due to infertility is often accompanied by many hypertension-related factors. We established a prospective cohort study based on assisted reproductive technology pregnancy population and natural pregnancy population. Through continuous monitoring of blood pressure changes and other risk factors during pregnancy in the two groups, we explored the trajectory trend and inflection point of assisted reproductive technology pregnancy population blood pressure during pregnancy. Through factor analysis, the risk factors of elevated blood pressure during pregnancy can be clearly identified, so as to carry out early intervention and strengthen the control of risk factors of elevated blood pressure in assisted reproductive technology population, in order to expect benign maternal and infant outcomes.
CONDITIONS
Official Title
The Trajectory of Blood Pressure During Pregnancy in Assisted Reproductive Females
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Mother seen in the hospital obstetrics department
- Mother completed at least one cycle of IVF, ICSI, PGD, or IVM treatment including natural cycles
- Clinical pregnancy achieved after assisted reproductive treatment
- Offspring born after in vitro fertilization-embryo transfer technique
- Mothers who conceived naturally
- Offspring born from natural pregnancy
- Offspring born from natural pregnancy of exposed mothers
You will not qualify if you...
- Unwilling to participate in this research
- Unable to participate due to death, immigration, or loss to follow-up
- Presence of hereditary diseases, mental illnesses, malignant tumors, pre-pregnancy hypertension, uterine malformations, or other reproductive organ malformations
- Pregnant women who voluntarily terminate pregnancy due to non-preeclampsia factors
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Cui linlin
Jinan, China
Actively Recruiting
Research Team
W
Wenting Wang, M.D. Ph.D.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here